Skip to main content
. 2015 Aug 24;6(31):31181–31190. doi: 10.18632/oncotarget.5070

Figure 2. Survival curves according to CHDIL expression level for NSCLC patients.

Figure 2

A, B. and C. overall survival for the whole cohort, SCC and ADC patients; D, E. and F. local-regional failure free survival for the whole cohort, SCC and ADC patients; and G, H. and I. distant metastasis free survival for the whole cohort, SCC and ADC patients. CHDIL normal expression groups are shown as solid lines; CHDIL overexpression groups are shown as dashed lines.